These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1799617)

  • 1. [Sensitivity of Acinetobacter calcoaceticus-baumanni complex and Acinetobacter lwoffi to common antibiotics].
    Reina J
    Enferm Infecc Microbiol Clin; 1991; 9(7):438-9. PubMed ID: 1799617
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization and changing minimum inhibitory concentration (MIC) of Acinetobacter species from a tertiary care setup.
    Capoor MR; Nair D; Srivastava L; Gupta B; Aggarwal P
    J Commun Dis; 2005 Jun; 37(2):99-107. PubMed ID: 16749272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sensitivity of bacteria of the genus Acinetobacter to antibiotics and ofloxacin].
    Fleischer M; Przondo-Mordarska A; Ruczkowska J
    Med Dosw Mikrobiol; 1991; 43(3-4):103-10. PubMed ID: 1823372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antibiotic sensitivity of Acinetobacter calcoaceticus in patients with infected burns].
    Borisova OK; Makarenkova RV; Bogatova IS; Kutsidi EV
    Antibiotiki; 1982 Jun; 27(6):447-50. PubMed ID: 7114831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Is sulbactam really the answer for treatment of infections caused by multiresistant strains of Acinetobacter spp.?].
    Casellas JM; Dana R
    Enferm Infecc Microbiol Clin; 1997; 15(6):335-6. PubMed ID: 9376409
    [No Abstract]   [Full Text] [Related]  

  • 6. Susceptibility of the Acinetobacter calcoaceticus-A. baumannii complex to imipenem, meropenem, sulbactam and colistin.
    Dueñas Díez AI; Bratos Pérez MA; Eiros Bouza JM; Almaraz Gómez A; Gutiérrez Rodríguez P; Miguel Gómez MA; Orduña Domingo A; Rodríguez-Torres A
    Int J Antimicrob Agents; 2004 May; 23(5):487-93. PubMed ID: 15120728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acinetobacter spp. and time-kill studies.
    Lopardo HA
    J Antimicrob Chemother; 2008 Feb; 61(2):464; author reply 464-6. PubMed ID: 18033781
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial resistance of Acinetobacter spp. in Europe.
    Van Looveren M; Goossens H;
    Clin Microbiol Infect; 2004 Aug; 10(8):684-704. PubMed ID: 15301671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concerning the sensitivity of Acinetobacter calcoaceticus.
    Jedlicková Z; Tesaríková E; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1990; 34(1):73-6. PubMed ID: 2351822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 11. [Genus Acinetobacter in human pathology].
    Constantiniu S; Lonescu G
    Bacteriol Virusol Parazitol Epidemiol; 2005; 50(1-2):3-16. PubMed ID: 17300026
    [No Abstract]   [Full Text] [Related]  

  • 12. [Microbiological and therapeutic considerations of Acinetobacter spp. infection].
    López-Brea M; Alarcón T; López S
    Rev Esp Quimioter; 1998 Jun; 11(2):110-7. PubMed ID: 9795295
    [No Abstract]   [Full Text] [Related]  

  • 13. [Presence of various Acinetobacter species in urinary tract infections].
    Gospodarek E; Sieradzka E; Bugalski R
    Med Dosw Mikrobiol; 1991; 43(3-4):111-8. PubMed ID: 1823373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of Acinetobacter strains identified by DNA-DNA hybridization.
    Tjernberg I
    APMIS; 1990 Apr; 98(4):320-6. PubMed ID: 2354051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Acinetobacter calcoaceticus, a potential pathogen with an increasing role in pathology].
    Georgescu C; Neguţ M; Marinescu L; Călin C; Boboc F; Georgescu-Brăila M; Florescu DP; Trifan G
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1984; 29(4):333-9. PubMed ID: 6522946
    [No Abstract]   [Full Text] [Related]  

  • 16. Characteristics of Acinetobacter strains (phenotype classification, antibiotic susceptibility and production of beta-lactamases) isolated from haemocultures from patients at the Teaching Hospital in Olomouc.
    Hejnar P; Kolár M; Hájek V
    Acta Univ Palacki Olomuc Fac Med; 1999; 142():73-7. PubMed ID: 10743729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative in vitro activity of 6 recent beta-lactams against hospital strains of Acinetobacter calcoaceticus: role of the monobactam SQ 26,776].
    Joly-Guillou ML; Serieys C; Verin-Prevost C; Bergogne-Berezin E
    Pathol Biol (Paris); 1983 May; 31(5):392-5. PubMed ID: 6353329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bactericide activity of sulbactam before bacteria belonging to the Acinetobacter calcoaceticus-Acinetobacter baumannii complex].
    Villar HE; Laurino G; Hoffman M
    Enferm Infecc Microbiol Clin; 1996 Nov; 14(9):524-7. PubMed ID: 9035707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
    Gales AC; Jones RN; Forward KR; Liñares J; Sader HS; Verhoef J
    Clin Infect Dis; 2001 May; 32 Suppl 2():S104-13. PubMed ID: 11320451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug-resistant Acinetobacter: a threat to the antibiotic era.
    Peleg AY; Paterson DL
    Intern Med J; 2006 Aug; 36(8):479-82. PubMed ID: 16866649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.